VITAL KSK HOLDINGS,INC.
3151・Prime Market・Wholesale Trade
VITAL KSK HOLDINGS,INC.3151
VITAL KSK HOLDINGS,INC.3151
Reference Indicators
Market Cap
866¥100M
P/E (Forecast)
10.8x
P/B
0.7x
Dividend Yield (Forecast)
4.20%
ROE
6.6%
EV/EBITDA
8.6x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 577,249 | 579,772 | 587,481 | 600,370 | 610,497 |
Cost of Sales | 533,272 | 534,809 | 539,179 | 551,155 | 560,915 |
Gross Profit | 43,976 | 44,963 | 48,301 | 49,214 | 49,581 |
SG&A Expenses | 41,030 | 42,492 | 42,745 | 43,508 | 45,553 |
Operating Income | 2,945 | 2,470 | 5,556 | 5,706 | 4,027 |
Non-operating Income | 3,100 | 3,682 | 1,379 | 1,471 | 4,071 |
Non-operating Expenses | 212 | 192 | 378 | 207 | 277 |
Ordinary Income | 5,834 | 5,960 | 6,557 | 6,970 | 7,822 |
Extraordinary Income | 2,873 | 4,224 | 2,630 | 4,276 | 4,219 |
Extraordinary Losses | 1,059 | 2,072 | 515 | 556 | 539 |
Pre-tax Income | 7,648 | 8,111 | 8,672 | 10,691 | 11,502 |
Income Taxes | 2,767 | 3,177 | 2,728 | 3,288 | 4,045 |
Net Income | 4,770 | 4,831 | 5,843 | 7,308 | 7,362 |
EBITDA | 6,068 | 5,823 | 8,944 | 9,492 | 8,076 |
Gross Margin | 7.6% | 7.8% | 8.2% | 8.2% | 8.1% |
Operating Margin | 0.5% | 0.4% | 0.9% | 1.0% | 0.7% |
ROA | 1.5% | 1.6% | 1.8% | 2.4% | 2.3% |
ROE | 4.7% | 4.9% | 5.7% | 6.9% | 6.6% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| 医薬品卸売事業 | 572,860 | 4,920 | 0.9% |
| 薬局事業 | 19,960 | 252 | 1.3% |
| 動物用医薬品卸売事業 | 12,627 | 304 | 2.4% |
| 製薬事業 | 0 | -1,312 | 0.0% |
| 介護レンタルその他事業 | 5,048 | -102 | -2.0% |